News Releases

Select year
Categories

Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status

Dec 22, 2008 | Products

Read more

Myriad Genetics, Inc. Receives Approval From New York Stock Exchange to Proceed With New Listing

Dec 16, 2008 | Financial

Read more

Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2009

Nov 04, 2008 | Financial

Read more

Myriad Genetics Announces First Quarter Fiscal 2009 Financial Results Conference Call

Oct 23, 2008 | Financial

Read more

Myriad Genetics Announces Plan to Separate Into Two Independent Public Companies

Oct 20, 2008 | Corporate

Read more

Myriad Genetics Acquires Novel Therapeutic Drug Management Technology From Saladax Biomedical

Oct 07, 2008 | Pipeline

Read more

MultiVu Video Feed: WOMEN WITH A HEREDITARY RISK OF BREAST AND OVARIAN CANCER ARE ENCOURAGED TO GET TESTED - THOSE WITH AN ALTERED BRCA1 OR BRCA2 GENE HAVE A 56 TO 87 PERCENT RISK TO DEVELOP BREAST CANCER BY AGE 70

Sep 23, 2008 | Products

Read more

Myriad Genetics Announces Topline Results of Phase 1 Trial of Vivecon for HIV

Sep 17, 2008 | Pipeline

Read more

Myriad Genetics Board Explores Prospect of Separating Diagnostic and Pharmaceutical Businesses

Sep 11, 2008 | Corporate

Read more

Myriad Genetics Reports Financial Results for Fiscal 2008

Aug 19, 2008 | Financial

Read more

Myriad Genetics Announces Fourth Quarter and Year-End Fiscal 2008 Financial Results Conference Call

Aug 19, 2008 | Financial

Read more

Myriad Genetics Reports Results of U.S. Phase 3 Trial of Flurizan™ in Alzheimer's Disease

Jun 30, 2008 | Products

Read more

Myriad Genetics' Alzheimer's Disease Drug Mechanism of Action Detailed in Nature Article

Jun 11, 2008 | Pipeline

Read more

Myriad Genetics Selects Lundbeck as European Partner for Flurizan

May 22, 2008 | Products

Read more

Myriad Genetics Reports Results for Third Quarter of Fiscal 2008

May 06, 2008 | Financial

Read more

Myriad Genetics Announces Third Quarter Fiscal 2008 Financial Results Conference Call

Apr 23, 2008 | Financial

Read more

Myriad Genetics to Present at Cowen Health Care Conference on March 18, 2008

Mar 06, 2008 | Corporate

Read more

Myriad Genetics to Present at the Lehman Brothers Healthcare Conference on March 19, 2008

Mar 06, 2008 | Corporate

Read more

Myriad Genetics Reports Results for Second Quarter of Fiscal 2008

Feb 05, 2008 | Financial

Read more

Myriad Genetics Announces Completion of Phase 1 Trial of Anti-Thrombin Drug MPC-0920

Jan 29, 2008 | Pipeline

Read more

Myriad Genetics, Inc. Expands Commercial and Clinical Infrastructure

Jan 23, 2008 | Corporate

Read more

Myriad Genetics Announces Second Quarter Fiscal 2008 Financial Results Conference Call

Jan 22, 2008 | Financial

Read more